Objective: We asked whether 60 compared with 240 min observation is sufficiently informative and safe for pregnancy day assessment (PDAC) of suspected pre-eclampsia (PE). Design: A retrospective study of 209 pregnant women (475 PDAC assessments, 6 months) with routinely collected blood pressure (BP), symptom and laboratory information. We proposed a 60 min screening algorithm comprising: absence of symptoms, normal laboratory parameters and ≤1high-BP reading (systolic blood pressure, SBP 140 mm Hg or higher or diastolic blood pressure, DBP 90 mm Hg or higher). We also evaluated two less inclusive screening algorithms. We determined short-term outcomes (within 4 h): severe hypertension, proteinuric hypertension and pregnancy-induced hyperten...
Pre-eclampsia is diagnosed when a pregnant woman develops i.e. blood pressure ≥140 mmHg systolic or ...
Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment ...
Objective To examine the performance of screening for pre-eclampsia (PE) and gestational hypertensio...
Objective: We asked whether 60 compared with 240 min observation is sufficiently informative and saf...
OBJECTIVE: We asked whether 60 compared with 240 min observation is sufficiently informative and saf...
STUDY QUESTION: Can routine antenatal blood pressure measurements between 20 and 36 weeks' gestation...
Objective: To determine the accuracy of using systolic and diastolic blood pressure, mean arterial p...
Objective: To examine the performance of screening for early, preterm and term pre-eclampsia (PE) at...
Objective: To examine the performance of screening for early, preterm and term pre-eclampsia (PE) at...
Objective: White coat hypertension (WCH) is a common phenomenon with a long term prognosis intermedi...
Study questionCan routine antenatal blood pressure measurements between 20 and 36 weeks’ gestation c...
OBJECTIVE: To examine the diagnostic accuracy of a previously developed model for prediction of pre-...
OBJECTIVE: The majority of patients with chronic or gestational hypertension do not develop pre-ecla...
OBJECTIVES: The risk of cardiovascular disease more than doubles after hypertensive disorders of pre...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a comb...
Pre-eclampsia is diagnosed when a pregnant woman develops i.e. blood pressure ≥140 mmHg systolic or ...
Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment ...
Objective To examine the performance of screening for pre-eclampsia (PE) and gestational hypertensio...
Objective: We asked whether 60 compared with 240 min observation is sufficiently informative and saf...
OBJECTIVE: We asked whether 60 compared with 240 min observation is sufficiently informative and saf...
STUDY QUESTION: Can routine antenatal blood pressure measurements between 20 and 36 weeks' gestation...
Objective: To determine the accuracy of using systolic and diastolic blood pressure, mean arterial p...
Objective: To examine the performance of screening for early, preterm and term pre-eclampsia (PE) at...
Objective: To examine the performance of screening for early, preterm and term pre-eclampsia (PE) at...
Objective: White coat hypertension (WCH) is a common phenomenon with a long term prognosis intermedi...
Study questionCan routine antenatal blood pressure measurements between 20 and 36 weeks’ gestation c...
OBJECTIVE: To examine the diagnostic accuracy of a previously developed model for prediction of pre-...
OBJECTIVE: The majority of patients with chronic or gestational hypertension do not develop pre-ecla...
OBJECTIVES: The risk of cardiovascular disease more than doubles after hypertensive disorders of pre...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a comb...
Pre-eclampsia is diagnosed when a pregnant woman develops i.e. blood pressure ≥140 mmHg systolic or ...
Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment ...
Objective To examine the performance of screening for pre-eclampsia (PE) and gestational hypertensio...